Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Holly Williams

AstraZeneca to overhaul US listing but remain on London market and keep UK HQ

The news comes during an increased focus by the company on the US amid efforts to lessen the impact of Donald Trump’s trade tariffs (Lynne Cameron/PA) - (PA Wire)

Drugs giant AstraZeneca has revealed plans to overhaul its US listing, but stressed it will keep its headquarters in the UK and remain on the London market.

Cambridge-based AstraZeneca is set to directly list its ordinary shares on the New York Stock Exchange (NYSE) from February next year in a move designed to help the group “reach a broader mix of global investors”.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.